Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1.
Yuko EharaMonji KogaShinichi ImafukuOsamu YamamotoYuichi YoshidaPublished in: The Journal of dermatology (2019)
Neurofibromatosis 1 (NF1) is a genetic disease characterized by cutaneous, neurological and osseous abnormalities. Approximately 20% of patients develop plexiform neurofibroma (PN), resulting in impaired quality of life. To evaluate distribution of diffuse PN on the body surface, a retrospective study was conducted for 354 patients with NF1 from 2007 to 2018 in Japan. We investigated a total of 40 patients with clinically apparent superficial diffuse PN. In the cases evaluated, 57.4% of the diffuse PN were located on the trunk, 19.2% the head and neck, 12.8% the lower limbs and 10.6% the upper limbs. Remarkably, 75.0% of the diffuse PN were located on the dorsal side. The frequency was significantly higher on the trunk than on the head and neck (P = 0.026). Our findings provide useful information for giving attention to the high possibility of diffuse PN on the dorsal side before progression in childhood and for future treatment in NF1.
Keyphrases
- peritoneal dialysis
- end stage renal disease
- low grade
- signaling pathway
- lps induced
- spinal cord
- pi k akt
- oxidative stress
- high grade
- nuclear factor
- neuropathic pain
- healthcare
- chronic kidney disease
- dna methylation
- ejection fraction
- newly diagnosed
- magnetic resonance
- lower limb
- genome wide
- blood brain barrier
- current status
- subarachnoid hemorrhage